• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名非荷兰籍p16-Leiden突变携带者,携带2个MC1R高风险变异体,在接受霍奇金淋巴瘤治疗后发生多发性黑色素瘤。

Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.

作者信息

Figl Adina, Thirumaran Ranjit K, Ugurel Selma, Gast Andreas, Hemminki Kari, Kumar Rajiv, Schadendorf Dirk

机构信息

Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.

出版信息

Arch Dermatol. 2007 Apr;143(4):495-9. doi: 10.1001/archderm.143.4.495.

DOI:10.1001/archderm.143.4.495
PMID:17438182
Abstract

BACKGROUND

A 19-base pair germline deletion in exon 2 of the CDKN2A (cyclin-dependent kinase inhibitor 2A) gene (Leiden mutation) has been detected in Dutch families with familial melanomas. The penetrance of CDKN2A mutations varies widely and is influenced by environmental and unrelated genetic factors such as variants in the MC1R gene.

OBSERVATIONS

We describe a 25-year-old German woman who developed 8 invasive melanomas and 6 in situ melanomas after radiation therapy and polychemotherapy for Hodgkin lymphoma. Genetic testing revealed a constitutional CDKN2A Leiden mutation in the proband and her sister, mother, and mother's sister. The proband also carried high-risk MC1R variant alleles R151C and R160W, which she had inherited from her father and her mother, respectively. The less affected mutation carrier sister did not have high-risk MC1R variant alleles. Analysis of DNA from paraffin-embedded tissues showed loss of heterozygosity at CDKN2A loci in all 3 melanomas studied but not in Hodgkin lymphoma. The pedigree revealed several types of cancers on both sides of the family, but no Dutch ancestors were found. No mutations in the CDK4, B-raf, and N-ras genes were detected either in the germline or in tumors from the patient.

CONCLUSION

This study shows the variability of the penetrance of the CDKN2A Leiden mutation within the same family, which could be due to genetic or exogenous factors.

摘要

背景

在患有家族性黑色素瘤的荷兰家族中,已检测到细胞周期蛋白依赖性激酶抑制剂2A(CDKN2A)基因第2外显子中的19个碱基对种系缺失(莱顿突变)。CDKN2A突变的外显率差异很大,并受环境和无关遗传因素(如MC1R基因中的变异)影响。

观察结果

我们描述了一名25岁的德国女性,她在接受霍奇金淋巴瘤的放疗和多药化疗后,发生了8例浸润性黑色素瘤和6例原位黑色素瘤。基因检测显示,先证者及其姐妹、母亲和母亲的姐妹存在先天性CDKN2A莱顿突变。先证者还携带高风险的MC1R变异等位基因R151C和R160W,分别从父亲和母亲那里遗传而来。受影响较小的突变携带者姐妹没有高风险的MC1R变异等位基因。对石蜡包埋组织的DNA分析显示,在所研究的所有3例黑色素瘤中,CDKN2A基因座存在杂合性缺失,但霍奇金淋巴瘤中未出现。家系显示家族双方有几种类型的癌症,但未发现荷兰祖先。在患者的种系或肿瘤中均未检测到CDK4、B-raf和N-ras基因的突变。

结论

本研究显示了同一家族中CDKN2A莱顿突变外显率的变异性,这可能是由于遗传或外源性因素导致的。

相似文献

1
Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.一名非荷兰籍p16-Leiden突变携带者,携带2个MC1R高风险变异体,在接受霍奇金淋巴瘤治疗后发生多发性黑色素瘤。
Arch Dermatol. 2007 Apr;143(4):495-9. doi: 10.1001/archderm.143.4.495.
2
Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.一名携带CDKN2A突变且暴露于电离辐射的患者发生多发性原发性黑色素瘤。
Arch Dermatol. 2007 Nov;143(11):1409-12. doi: 10.1001/archderm.143.11.1409.
3
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.MC1R 变异增加 CDKN2A 突变家族的黑色素瘤风险:一项荟萃分析。
Eur J Cancer. 2010 May;46(8):1413-20. doi: 10.1016/j.ejca.2010.01.027. Epub 2010 Feb 26.
4
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.无色素性和色素性黑色素瘤中CDKN2A和MC1R分析
Melanoma Res. 2009 Jun;19(3):142-5. doi: 10.1097/CMR.0b013e32832a1e18.
5
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.意大利单发性或多发性原发性黑色素瘤患者的CDKN2A突变和MC1R变异体
Pigment Cell Melanoma Res. 2008 Dec;21(6):700-9. doi: 10.1111/j.1755-148X.2008.00512.x. Epub 2008 Oct 22.
6
MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.地中海人群散发性和家族性黑色素瘤中的MC1R、ASIP与DNA修复
J Natl Cancer Inst. 2005 Jul 6;97(13):998-1007. doi: 10.1093/jnci/dji176.
7
CDKN2A mutations in multiple primary melanomas.多原发性黑色素瘤中的CDKN2A突变
N Engl J Med. 1998 Mar 26;338(13):879-87. doi: 10.1056/NEJM199803263381305.
8
Phenotypic variation in familial melanoma: consequences for predictive DNA testing.家族性黑色素瘤的表型变异:对预测性DNA检测的影响。
Arch Dermatol. 2007 Apr;143(4):525-6. doi: 10.1001/archderm.143.4.525.
9
[From gene to disease; from p16 to melanoma].[从基因到疾病;从p16到黑色素瘤]
Ned Tijdschr Geneeskd. 2000 Oct 28;144(44):2100-2.
10
Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.斯洛文尼亚黑色素瘤家族中黑色素瘤易感基因变异的患病率。
BMC Med Genet. 2008 Sep 19;9:86. doi: 10.1186/1471-2350-9-86.

引用本文的文献

1
A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma.一名患有星形细胞瘤和多发性黑色素瘤的女孩存在大片从头 9p21.3 缺失。
BMC Med Genet. 2014 May 17;15:59. doi: 10.1186/1471-2350-15-59.
2
Reciprocal responses of fibroblasts and melanocytes to α-MSH depending on MC1R polymorphisms.成纤维细胞和黑素细胞对α-促黑素(α-MSH)的相互反应取决于黑素皮质素1受体(MC1R)多态性。
Dermatoendocrinol. 2011 Oct;3(4):259-65. doi: 10.4161/derm.3.4.17454. Epub 2011 Oct 1.
3
Modification of second cancer risk after malignant melanoma by parental history of cancer.
恶性黑色素瘤后第二癌症风险受父母癌症病史的影响。
Br J Cancer. 2008 Aug 5;99(3):536-8. doi: 10.1038/sj.bjc.6604489. Epub 2008 Jul 15.